TLR2–TLR4/CD14 polymorphisms and predisposition to severe invasive infections by Neisseria meningitidis and Streptococcus pneumoniae
- 1 August 2014
- journal article
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 38 (6) , 356-362
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001BMC Infectious Diseases, 2009
- Stages of Meningococcal Sepsis Simulated In Vitro, with Emphasis on Complement and Toll-Like Receptor ActivationInfection and Immunity, 2008
- Pyogenic Bacterial Infections in Humans with MyD88 DeficiencyScience, 2008
- Two Neisseria meningitidis Strains with Different Ability to Stimulate Toll‐Like Receptor 4 Through the MyD88‐Independent PathwayScandinavian Journal of Immunology, 2006
- Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better?The Lancet Infectious Diseases, 2006
- Human Toll‐Like Receptor 4 Mutations but Not CD14 Polymorphisms Are Associated with an Increased Risk of Gram‐Negative InfectionsThe Journal of Infectious Diseases, 2002
- Toll‐Like Receptor 2–Deficient Mice Are Highly Susceptible toStreptococcus pneumoniaeMeningitis because of Reduced Bacterial Clearing and Enhanced InflammationThe Journal of Infectious Diseases, 2002
- A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal InfectionInfection and Immunity, 2000
- Differential roles of TLR2 and TLR4 in the host response to Gram-negative bacteria: lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidisInnate Immunity, 2000
- HUMAN IMMUNITY TO THE MENINGOCOCCUSJournal of Experimental Medicine, 1969